AU2002239259A1 - Controlled release formulation of divalproex sodium - Google Patents

Controlled release formulation of divalproex sodium

Info

Publication number
AU2002239259A1
AU2002239259A1 AU2002239259A AU2002239259A AU2002239259A1 AU 2002239259 A1 AU2002239259 A1 AU 2002239259A1 AU 2002239259 A AU2002239259 A AU 2002239259A AU 2002239259 A AU2002239259 A AU 2002239259A AU 2002239259 A1 AU2002239259 A1 AU 2002239259A1
Authority
AU
Australia
Prior art keywords
controlled release
release formulation
divalproex sodium
divalproex
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239259A
Inventor
J. Daniel Bollinger
Howard S. Cheskin
Sandeep Dutta
Kevin R. Engh
Richard P. Poska
Yihong Qiu
Kenneth W. Sommerville
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU2002239259A1 publication Critical patent/AU2002239259A1/en
Abandoned legal-status Critical Current

Links

AU2002239259A 2000-12-22 2001-12-04 Controlled release formulation of divalproex sodium Abandoned AU2002239259A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/748,567 2000-12-22
US09/877,681 2001-06-08

Publications (1)

Publication Number Publication Date
AU2002239259A1 true AU2002239259A1 (en) 2002-07-08

Family

ID=

Similar Documents

Publication Publication Date Title
HK1043043A1 (en) Controlled release formulation of divalproex sodium
AU2002225855A1 (en) Preparation of nanocrystallites
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2002244154A1 (en) Divalproex sodium tablets
AU2001286677A1 (en) Controlled release of substances
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU2002352974A1 (en) Formulations for oral administration of cromolyn sodium
AU2093101A (en) Compositions for efficient release of active ingredients
IL149033A0 (en) Extended release formulations of erythromycin derivatives
AU2001284324A1 (en) Controlled release formulation of erythromycin or a derivative thereof
AU2001297631A1 (en) Novel formulations of carvedilol
AU2001287977A1 (en) Controlled release formulations for oral administration
AU2001227030A1 (en) Pharmaceutical composition for controlled release of an active ingredient
AU2001248336A1 (en) Controlled release oral solid forms containing mesalazine as active agent
AU2001232948A1 (en) Controlled release of drugs
AU6386801A (en) System for the release of active ingredients
AU2001284763A1 (en) Preparation of risperidone
AU2002219175A1 (en) Crystalline forms of cerivastatin sodium
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU6589200A (en) Extended release formulation of etodolac
AU5765700A (en) Preparation of a therapeutic composition
AU2002222148A1 (en) Preparation of spheroids
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations
AU2001244108A1 (en) Formulations for states of dehydration
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof